Omeros Corporation (OMER)
NASDAQ: OMER
· Real-Time Price · USD
3.25
0.04 (1.09%)
At close: May 19, 2025, 10:37 AM
1.09% (1D)
| Bid | 3.15 |
| Market Cap | 190.43M |
| Revenue (ttm) | 412K |
| Net Income (ttm) | -153.09M |
| EPS (ttm) | -3.14 |
| PE Ratio (ttm) | -1.04 |
| Forward PE | -7.75 |
| Analyst | Hold |
| Ask | 3.31 |
| Volume | 445,906 |
| Avg. Volume (20D) | 880,652 |
| Open | 3.18 |
| Previous Close | 3.21 |
| Day's Range | 3.09 - 3.28 |
| 52-Week Range | 2.97 - 13.60 |
| Beta | 2.42 |
About OMER
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OMER
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OMER stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Omeros has released their quartely earnings
on May 15, 2025:
2 months ago
+3.89%
Omeros shares are trading after the company announ...
Unlock content with
Pro Subscription
5 months ago
+37.27%
Omeros shares are trading higher after the company announced that narsoplimab met its primary trial endpoint and will resubmit its narsoplimab Biologics License Application to the FDA.
